财务摘要（报告期）（Madrigal Pharmaceuticals Inc）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 每股指标： | ||||||||
| 每股收益EPS基本(元) | - | -14.27 | -8.91 | -4.23 | -17.23 | -12.25 | -7.50 | -3.36 |
| 每股净资产(元) | 20.53 | 1.20 | 5.61 | 8.21 | 10.90 | 0.62 | 4.88 | 8.52 |
| 每股经营现金净流量(元) | -16.42 | -13.21 | -8.63 | -4.60 | -12.42 | -9.73 | -6.27 | -2.92 |
| 每股现金流量净额(元) | -11.73 | -14.57 | -13.78 | -11.94 | 16.31 | 1.35 | 0.99 | 0.35 |
| 盈利能力： | ||||||||
| 净资产收益率平均(%) | - | -238.06 | -108.14 | -44.25 | -150.12 | -202.58 | -91.72 | -33.65 |
| 总资产净利率(%) | - | -87.07 | -48.93 | -22.13 | -92.89 | -96.97 | -52.38 | -23.19 |
| 投入资本回报率ROIC(%) | - | -252.68 | -126.96 | -61.48 | -220.34 | -124.53 | -64.09 | -27.56 |
| 收益质量： | ||||||||
| 营业利润／利润总额(%) | - | 100.72 | 101.28 | 101.87 | 99.40 | 99.44 | 99.70 | 100.12 |
| 资本结构： | ||||||||
| 资产负债率(%) | 36.72 | 90.65 | 65.78 | 54.84 | 45.56 | 93.27 | 61.40 | 34.54 |
| 权益乘数 | 1.58 | 10.70 | 2.92 | 2.21 | 1.84 | 14.87 | 2.59 | 1.53 |
| 产权比率 | 0.58 | 9.70 | 1.92 | 1.21 | 0.84 | 13.87 | 1.59 | 0.53 |
| 流动资产／总资产(%) | 99.49 | 98.95 | 99.71 | 99.65 | 99.67 | 99.03 | 99.15 | 99.33 |
| 非流动资产／总资产(%) | 0.51 | 1.05 | 0.29 | 0.35 | 0.33 | 0.97 | 0.85 | 0.67 |
| 流动负债／负债合计(%) | 50.40 | 46.20 | 50.11 | 53.94 | 70.16 | 66.85 | 63.23 | 99.63 |
| 非流动负债／负债合计(%) | 49.60 | 53.80 | 49.89 | 46.06 | 29.84 | 33.15 | 36.77 | 0.37 |
| 归属母公司股东的权益／投入资本(%) | 74.97 | 12.65 | 45.95 | 68.51 | 636.27 | 10.74 | 51.21 | 80.80 |
| 偿债能力： | ||||||||
| 流动比率 | 5.38 | 2.36 | 3.02 | 3.37 | 3.12 | 1.59 | 2.55 | 2.89 |
| 速动比率 | 5.38 | 2.36 | 3.02 | 3.37 | 3.12 | 1.59 | 2.55 | 2.89 |
| 货币资金／流动负债(%) | 84.28 | 62.26 | 77.42 | 115.21 | 286.08 | 59.99 | 63.41 | 55.17 |
| 营业利润／流动负债(%) | - | -264.21 | -165.27 | -79.65 | -253.31 | -210.55 | -152.20 | -75.14 |
| 经营活动产生的现金流量净额／流动负债(%) | -273.50 | -245.12 | -159.85 | -85.48 | -194.02 | -168.16 | -127.69 | -65.13 |
| 归属母公司股东的权益／负债合计(%) | 172.33 | 10.31 | 52.02 | 82.35 | 119.50 | 7.21 | 62.88 | 189.48 |
| 经营活动产生的现金流量净额／负债合计(%) | -137.84 | -113.25 | -80.11 | -46.11 | -136.13 | -112.41 | -80.74 | -64.89 |
| 营业利润／负债合计(%) | - | -122.07 | -82.83 | -42.97 | -177.72 | -140.75 | -96.24 | -74.87 |
| 成长能力： | ||||||||
| 总资产同比增长率(%) | 76.67 | 50.00 | 39.77 | 49.31 | 32.65 | -47.93 | -34.02 | -28.11 |
| 每股净资产同比增长率(%) | 88.29 | 92.84 | 14.81 | -3.63 | -4.90 | -95.52 | -70.04 | -47.47 |
| 总负债同比增长率(%) | 42.40 | 45.78 | 49.75 | 137.02 | 113.90 | 111.95 | 131.85 | 56.41 |
| 基本每股收益同比增长率(%) | - | -16.49 | -18.80 | -25.89 | -17.77 | -13.01 | -6.38 | -1.20 |
| 归属母公司股东的权益同比增长率(%) | 105.35 | 108.52 | 23.91 | 3.01 | 0.65 | -95.46 | -69.14 | -44.06 |
| 营业利润同比增长率(%) | - | -26.43 | -28.88 | -36.03 | -21.07 | -17.09 | -11.45 | -8.70 |
| 股东权益合计同比增长率(%) | 105.35 | 108.52 | 23.91 | 3.01 | 0.65 | -95.46 | -69.14 | -44.06 |
| 营运能力： | ||||||||
| 衍生指标： | ||||||||
| 现金及现金等价物净增加额TTM(元) | -231,634,000.00 | 2,715,000.00 | 23,924,000.00 | 71,026,000.00 | 295,280,000.00 | 10,166,000.00 | 19,732,000.00 | -1,923,000.00 |
| 利润总额TTM(元) | -347,341,000.00 | -347,341,000.00 | -329,798,000.00 | -314,728,000.00 | -295,350,000.00 | -273,994,000.00 | -255,897,000.00 | -246,818,000.00 |
| 投入资本(元) | 540,632,000.00 | 175,909,000.00 | 225,265,000.00 | 219,141,000.00 | 31,023,000.00 | 99,304,000.00 | 163,120,000.00 | 180,380,000.00 |
| 经营活动产生的现金流量净额TTM(元) | -324,230,000.00 | -302,812,000.00 | -276,961,000.00 | -259,011,000.00 | -224,857,000.00 | -214,393,000.00 | -200,880,000.00 | -190,401,000.00 |
| 归属母公司净利润TTM(元) | -347,341,000.00 | -347,341,000.00 | -329,798,000.00 | -314,728,000.00 | -295,350,000.00 | -273,994,000.00 | -255,897,000.00 | -246,818,000.00 |